Merdury Biopharmaceutical Corporation
Update：2025/12/24
Industries
Main Industry
Biotechnology
Main Product/Service
Merdury offers custom drug formulation and manufacturing services based on its StackDose™ platform — including formulation design, small‑scale prototyping, development of specialized tablet structures, and 3D‑printing mass‑production — and licenses its te
Founded Year
2019
Unified Business No.
82959747
Status
Active
Number of Employees
19
Total Paid-in
Capital
106,228,147 (NT$)
Location of Company
Taiwan
, New Taipei City
Exit Status
Emerging Stock Exchange(2022)
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, Ministry of Economic Affairs.
Exclusive content for members
Members-only content. Please log in to access.
Introduction
Merdury Biopharmaceutical Corporation, founded in 2019, is a pharmaceutical company dedicated to leveraging advanced 3D powder‑printing processes to innovate drug formulation and manufacturing; through its proprietary StackDose™ platform, it aims to devel
